The Claim
Viral pneumonia occurs in 16.2% of hospitalized COVID-19 patients, acute respiratory distress syndrome (ARDS) occurs in 6.6% of hospitalized COVID-19 patients, and lung injury is a primary driver of severe illness in these patients.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Among hospitalized patients with COVID-19, viral pneumonia affects 16.2% and acute respiratory distress syndrome affects 6.6%. Lung injury is the main cause of severe illness in these patients.
See the scientific wording
Viral pneumonia and acute respiratory distress syndrome (ARDS) are the most frequent complications in hospitalized COVID-19 patients, occurring in 16.2% and 6.6% of cases respectively, indicating that lung injury is a primary driver of severe illness.
The virus infects lung cells, causing them to die and release signals that attract immune cells. These immune cells flood the lungs, releasing chemicals that make blood vessels leaky. Fluid builds up in the air sacs, blocking oxygen from entering the blood and causing severe breathing trouble.
What the research says
1 studyThis big global study tracked what happened to hundreds of thousands of hospitalized COVID patients and found that many got serious lung problems like pneumonia and ARDS — exactly what the claim says.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.